We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+28.17%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$3.55B
AUM Growth
+$522M
Cap. Flow
-$54.7M
Cap. Flow %
-1.54%
Top 10 Hldgs %
31.77%
Holding
144
New
18
Increased
29
Reduced
10
Closed
28

Top Buys

Rank Stock Value
1
BEP icon
Brookfield Renewable
BEP
+$36.7M
2
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$29.3M
3
TREX icon
Trex
TREX
+$26.3M
4
NOVT icon
Novanta
NOVT
+$24.2M
5
DT icon
Dynatrace
DT
+$18.1M

Top Sells

Rank Stock Value
1
TMX
Terminix Global Holdings, Inc.
TMX
+$41.9M
2
PEGI
Pattern Energy Group Inc. Class A
PEGI
+$28.9M
3
ANET icon
Arista Networks
ANET
+$28M
4
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
+$22.6M
5
SRPT icon
Sarepta Therapeutics
SRPT
+$22.5M

Sector Composition

Rank Sector Weight
1 Healthcare 46.72%
2 Technology 21.45%
3 Industrials 9.37%
4 Consumer Discretionary 6.67%
5 Utilities 3.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARGX icon
26
argenx
ARGX
$54.6B
$47.7M 1.34%
297,300
+67,300
+29% +$9.1M
CCI icon
27
Crown Castle
CCI
$33.4B
$45.9M 1.29%
323,100
+4,500
+1% +$614K
VMC icon
28
Vulcan Materials
VMC
$35.2B
$45.9M 1.29%
318,900
+1,600
+0.5% +$229K
EXAS
29
DELISTED
Exact Sciences
EXAS
$45.8M 1.29%
495,000
– –
GWPH
30
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$45.6M 1.28%
436,000
+261,000
+149% +$29.3M
MYOK
31
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$45.3M 1.28%
621,000
– –
STML
32
DELISTED
Stemline Therapeutics, Inc.
STML
$44.2M 1.25%
4,160,608
– –
SMAR
33
DELISTED
Smartsheet Inc.
SMAR
$43.8M 1.23%
975,000
– –
BEP icon
34
Brookfield Renewable
BEP
$9.9B
$42.5M 1.2%
1,711,743
+1,554,305
+987% +$36.7M
GBT
35
DELISTED
Global Blood Therapeutics, Inc.
GBT
$42.5M 1.2%
535,000
– –
POOL icon
36
Pool Corp
POOL
$6.95B
$39.3M 1.11%
185,000
– –
MRTX
37
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$38.8M 1.09%
301,000
– –
NBIX icon
38
Neurocrine Biosciences
NBIX
$18.7B
$37.9M 1.07%
353,000
– –
BPMC
39
DELISTED
Blueprint Medicines
BPMC
$37M 1.04%
462,000
– –
QURE icon
40
uniQure
QURE
$2.93B
$35.8M 1.01%
500,000
– –
IPHI
41
DELISTED
INPHI CORPORATION
IPHI
$33.3M 0.94%
450,000
-105,000
-19% -$7.21M
VRNS icon
42
Varonis Systems
VRNS
$4.58B
$32.6M 0.92%
1,260,000
– –
RCKT icon
43
Rocket Pharmaceuticals
RCKT
$351M
$32.2M 0.91%
1,415,000
– –
MGA icon
44
Magna International
MGA
$19B
$32.2M 0.91%
587,000
– –
KALV
45
DELISTED
KalVista Pharmaceuticals
KALV
$29.9M 0.84%
1,680,000
– –
CTAS icon
46
Cintas
CTAS
$82.7B
$29.9M 0.84%
444,000
– –
IAA
47
DELISTED
IAA, Inc. Common Stock
IAA
$28.7M 0.81%
610,000
– –
TREX icon
48
Trex
TREX
$4.56B
$26.9M 0.76%
+598,000
New +$26.3M
IDXX icon
49
Idexx Laboratories
IDXX
$44.1B
$26.9M 0.76%
102,900
– –
ODFL icon
50
Old Dominion Freight Line
ODFL
$44.2B
$26.6M 0.75%
421,200
+16,200
+4% +$995K
1
2
3 4 5

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q4 2019 Portfolio in Review

As of Q4 2019, Eventide Asset Management held 144 positions worth $3.55B, up 17% from $3.03B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Eventide Asset Management's Q4 2019 filing shows 18 new, 29 increased, 10 reduced and 28 closed positions. Its largest new stake was Trex: 598,000 shares worth $26.9M. The largest sale was Terminix Global Holdings, Inc., an estimated $41.9M.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, up from 42% a quarter earlier, followed by Technology and Industrials.

  • Eventide Asset Management's largest Q4 2019 buy was Trex: 598,000 shares worth $26.9M.
  • Eventide Asset Management added most to Brookfield Renewable in Q4 2019, an estimated $36.7M increase.
  • Eventide Asset Management's biggest Q4 2019 reduction was Lakefront Biotherapeutics American Depositary Shares, cutting an estimated $22.6M.
  • Eventide Asset Management fully exited Terminix Global Holdings, Inc. in Q4 2019, selling an estimated $41.9M.
  • Eventide Asset Management's ten largest holdings make up 32% of its $3.55B portfolio in Q4 2019.
  • Eventide Asset Management opened 18 new positions and closed 28 in Q4 2019.
  • Eventide Asset Management's portfolio value rose 17% quarter-over-quarter to $3.55B.

Based on Eventide Asset Management's 13F filing for Q4 2019, filed 29 Jan 2020.